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CASE REPORT
Fig. 1. Brown-colored cutaneous nodule on the linear scar of 
right girdle area. 
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Extraskeletal osteosarcoma (ESOS) is a very rare malignant 
tumor of mesenchymal origin. It is rarer than osseous 
osteosarcoma and there are very few reports of the skin being 
a primary site. Most reported cutaneous ESOS were 
accompanied with metastasis in other organs. A 56-year-old 
man presented with a painful, 1.5×0.8 cm sized, brown- 
colored nodule on the right girdle area for 3 months. The 
histologic findings revealed a tumor that was confined to the 
dermis without connection to the subcutaneous tissue. In 
addition, there were large amounts of thin and lace-like bony 
trabeculae and osteoid with neoplastic cells in a highly 
pleomorphic sarcomatous stroma. (Ann Dermatol 23(S2) 
S160∼S164, 2011)
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INTRODUCTION
Extraskeletal osteosarcoma (ESOS) is defined as a 
malignant mesenchymal neoplasm that produces osteoid, 
bone, and/or chondroid material, and is located in the soft 
tissues without attachment to the bone or periosteum
1. 
ESOS occurs rarely, with an incidence of 4∼5% of 
osteosarcoma
2,3 and 1% of soft tissue sarcoma
4. Up to 
13% of cases have been reported with association to 
previous trauma or irradiation, but the etiological 
correlation of mechanical injury is difficult to assess
1,5. It 
presents as a progressively enlarging soft tissue mass, 
which is painful in about one third of patients. The 
duration of symptoms vary from a few weeks to several 
months with a mean of 6.5 months
4. Approximately 10% 
of reported ESOSs are superficially located in soft tissue. 
ESOS in skin develops de novo or by metastasis and is 
exceedingly rare. Herein, we describe a 56-year-old 
patient that presented with a nodule on a scar in the right 
girdle area, with a review of the literature.
CASE REPORT
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Fig. 2. Extension of mid- to lower dermis by solid tumor (H&E,
×40).
Fig. 4. Microscopic finding of the periphery of the tumor: plump
osteoid in a stroma of malignant tumor cells and osteoclast-like
giant cells are observed (H&E, ×200).
Fig. 3. Microscopic finding of central portion of the tumor: a 
large amount of thin and lace-like bony trabeculae and osteoid 
with intervening malignant osteoblasts are seen (H&E, ×100).
growing nodule located on the right girdle area (Fig. 1). 
On physical examination, a firm, non-ulcerated, 1.5×0.8 
cm sized, brown-colored exophytic nodule was observed 
on a linear scar of the right girdle area. The lesion 
presented 3 months ago, and had been preceded by 
intermittent pricking pain without specific skin lesions. 
Ten years ago, the patient went to a local physician with 
intermittent left foot pain. X-ray showed an osteolytic 
lesion in the fourth and fifth metatarsal bone of his left 
foot. He had undergone curettage and autogenous bone 
graft that was taken from the right iliac crest. Pathologic 
interpretation was osteoblastoma. He showed positive 
results for several weeks, but then developed pain and 
swelling on the distal portion of his left leg. X-ray showed 
progression of the osteolytic lesion and soft tissue swelling 
in his left foot. He had an additional biopsy for evaluation, 
which revealed osteosarcoma. Following that, an ampu-
tation was performed below the left knee. Postoperatively, 
he was not given adjuvant chemotherapy, radiotherapy or 
trauma in the tumor area.
The tumor was excised with a clinical diagnosis of 
dermatofibroma. Microscopically, the tumor was confined 
to the dermis without connection to subcutaneous tissue 
(Fig. 2). Large amounts of thin and lace-like bony 
trabeculae and osteoid formed by neoplastic cells were 
observed in a highly pleomorphic sarcomatous stroma 
(Fig. 3). The neoplastic bone and osteoid exhibited an 
oteoblastic rim (Fig. 4). Immnunohistochemically, tumor 
cells were immunoreactive for vimentin, but negative for 
S-100 protein, desmin, and cytokeratin.
Beyond histopathological examination, physical findings 
and laboratory tests were within normal limits, and 
positron emission tomography-computed tomography (PET- 
CT) revealed no other bone involvement. The final 
diagnosis was primary cutaneous osteoblastic ESOS, 
which developed on previously traumatized skin as an 
operation scar. The patient improved without relapse or 
metastases for 18 months.
DISCUSSION
ESOS, initially described by Wilson
6 in 1941, is a 
malignant mesenchymal neoplasm arising in soft tissues SG Park, et al
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Table 1. Review of reported cases of primary cutaneous extraskeletal osteosarcomas
Author Case Age/Sex Site Size Follow up Histological type Notes
Drut (1975) 1  70/F Right thigh 12 cm No recurrence Osteoblastic Arisen in old burn scar
Fletcher (1987) 2   − Lower leg    −       −       − Arisen in chronic 
    tropical ulcers
Chung (1987) 2   −      −    −       −       − Confined to the sub-
 cutis or dermis
Reyes (1989) 1  62/M Temporoparietal 5×3 cm No recurrence Fibroblastic Previous RTx. for 
 epiauricular BCC 
Kuo (1992) 1  51/F Popliteal area 3×3 cm       − Osteo/fibroblastic         −
Kobos (1995) 1  78/M Shoulder 1×1 cm Local recurrence Osteoblastic         −
Kircik (1995) 1  83/F Frontal/parietal Large Lung metastasis        − Previous trauma
Pillay (2000) 1  56/F Scalp 8 cm Neck metastasis Osteo/fibroblastic         −
Santos-Juanes (2004) 1  96/F Temple 4×3 cm No recurrence Osteo/telangiectatic Previously 
 electrodessicated AK
Massi (2006)
9 1  84/M Scalp 2×2 cm No recurrence Osteoblastic Previously 
 electrodessicated AK
Salamanca (2008)
10 1 60/M Right thigh 9×6×5 cm Lung metastasis Chondroblastic          −
Song (2009) 1  56/M Right girdle area 1.5×0.8 cm No recurrence Osteoblastic Arisen in  operation scar
Several articles do not mention about the information of precise tumor’s histological type but we can infer from the descriptions
of histology and the figures. F: female, M: male, RTx.: radiotherapy, BCC: basal cell carcinoma, AK: actinic keratosis, Osteo: osteoblastic.
with no connection to skeletal structures, and composed 
of cells producing osteoid, bone, and/or chondroid 
material. Based on the predominant matrix, ESOS is 
divided microscopically into six distant subtypes, which 
include fibroblastic, osteoblastic, chondroblastic, oste-
oclastic or giant cell, telangiectatic, and small cell 
osteosarcoma
1. ESOS usually occurs in patients over 
40-years-old (mean age 47.5 years) with equal gender 
incidence; in contrast to primary osseous osteosarcoma its 
peak incidence in the 2nd decade of life. ESOS most 
commonly affects lower extremities, and in particular the 
thighs and other sites include the upper extremities, 
shoulder and retroperitoneum. A majority of cases of 
ESOS have been found in deep soft tissue
7, but have rarely 
been confined to the subcutis or even the dermis
2,5,8. The 
clinical course of ESOS is aggressive, and tumor- related 
mortality is 75% within 5 years of diagnosis. Tumor size 
(＜5 cm versus ≥5 cm) appears to be the only reliable 
prognostic variable. However, histological subtypes are 
regarded by some as another variable of clinical course, 
and chondroblastic type has a slightly favorable outcome 
compared to the rest.
Cutaneous ESOS usually develops by de novo or meta-
stasis. Skin as a primary site is rare and only 13 cases of 
primary cutaneous osteosarcoma have been reported to 
date (Table 1)
5,7,9,10. With an exception of 2 undocu-
mented cases, it occurred either on the cephalic area (5 
cases) or in the extremities (lower leg 5 cases, and shoulder 
1 case). The age distribution of primary cutaneous ESOS 
ranged from 51 to 96-years-old with a mean age of 70 
years and most of them had a relatively short duration of 
less than one year. In most cases that occurred on the 
cephalic area, they arose at the site of a preceding insult, 
such as electrodessication (2 cases), radiotherapy (1 case) 
and trauma (1 case), whereas there was no previous insult 
in 6 cases that occurred in the extremities. Three cases 
that were over 5 cm in size were metastasized to the lung 
within a few months after initial diagnosis, but had no 
distinct histological types that were clearly related to the 
prognosis.
Bone tumor metastasis almost exclusively spreads 
hematogenously, and rarely by lymphatic dissemination, 
or direct dissemination to overlying skin of the primary 
lesion, or implantation
11. A metastasis of bone tumor mani-
fested by pulmonary involvement in the early stage and 
secondarily by involvement of other sites, such as distant 
bone, brain, lymph node, and other retroperitoneal 
sites
12,13.
Cutaneous metastasis, whether from osteosarcoma or 
ESOS, appears to be exceedingly rare, as there are only 11 
cases reported in the literature (Table 2)
11-20. In most cases 
of skin metastasis, solitary or multiple lesions appeared, 
except in 2 undocumented cases, and all solitary lesions 
developed in the cephalic area.
The average age of metastatic cutaneous ESOS is 39.5 
years lower than that of primary cutaneous ESOS, as it 
spreads to the skin from the osteosarcoma that is 
developed at an early age. Until cutaneous metastasis 
develops, they progress relatively fast at a mean of 12 
months and are accompanied with distant metastasis to Cutaneous Extraskeletal Osteosarcoma on the Scar of a Previous Bone Graft
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Table 2. Review of reported cases of metastatic cutaneous extraskeletal osteosarcomas 
Author Case Age/Sex Site Type Primary site Duration Histological type Notes
Brownstein (1972)
141  −        − Metastatic (OS)      −   −     −       −
Bacci (1988)
15 1  −        − Metastatic (OS)      −   −     −       −
Myhand (1995)
12 1 21/M Rt. clavicle (S) Metastatic (OS) Rt. clavicle  2 mo     −       −
Setoyama (1996)
16 1 24/M Temple (S) Metastatic (OS) Humerus  4 yr Osteoblastic Lung metastasis
Stavrakakis (1997)
171 54/F Abdomen wall, scalp Metastatic (OS) Femur  3 mo Fibroblastic       −  
ten Harkel (1997)
131 14/M Scalp (S) Metastatic (OS) Femur  4 wk     − Brain metastasis
Vaidya (2002)
18 1 16/M Thigh, scapular, Metastatic (OS) Calcaneus  3 mo     − Lung metastasis
 abdomen wall
Collier (2003)
11 2 75/F Knee, scalp Metastatic (OS) Proximal tibia  3 mo Osteoblastic/ Lung metastasis
fibroblastic
46/F Thigh Knee 20 yr     − Lung, scalp 
 metastasis
Covello (2003)
19 1 83/F Scalp (S) Metastatic (ESOS) Breast 18 mo Osteoblastic Lung, liver, spine,
 pelvis, and brain
 metastasis
Lee (2008)
20 1 48/F Scalp (S) Metastatic (ESOS) Mediastinum  2 mo Chondroblastic Lung metastasis
Several articles do not mention about the information of precise tumor’s histological type but we can infer from the descriptions
of histology and the figures. F: female, M: male, Rt: right, S: solitary, OS: osteosarcoma, ESOS: extraskeletal osteosarcoma.
the lung or brain. It seems that there is no interrelationship 
between histological type and prognosis.
Due to the loss of data, we could not identify whether the 
histological type between the previous osseous oste-
osarcoma and the present cutaneous ESOS was identical 
or not. However, the previous tumor was completely 
removed and recurrence or other metastatic lesions were 
not observed. In addition, the interval of tumor deve-
lopment was quite long (10 years) compared to reported 
metastatic cases and no metastatic lesion on PET-CT was 
observed. Therefore, we diagnosed that this case was a 
primary cutaneous ESOS occurring on the operation scar. 
However, we could not completely rule out a metastatic 
ESOS because there was one report
11, in which metastatic 
ESOS developed after 20 years of the primary osteosar-
coma.
When making a differential diagnosis, bone forming soft 
tissue tumors such as myositis ossificans and sarcomas 
with osseous metaplasia including fibrosarcoma, malig-
nant fibrous histocytoma, synovial sarcoma, epithelioid 
fibrosarcoma, and liposarcoma should be excluded. Other 
ossified tumors originating in the skin should also be 
considered. Osteoma cutis shows mature ossification 
without atypia or mitosis. Metaplastic ossification may 
also be seen in benign or malignant cutaneous tumors 
including pilomatricoma, intradermal nevus, desmoplastic 
malignant melanoma, basal cell carcinoma, and chond-
roid syringoma. In our case, the clinical and histo-
pathological features supported a diagnosis of cutaneous 
ESOS.
Close long-term follow up will be needed for our patient 
including regular physical examinations and radiological 
studies because of less favorable osteoblastic histo-
pathologic type, although the patient had a tumor less 
than 5 cm and no evidence of another distant metastasis 
was found, particularly in the lung.
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